Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

Efficacy of canakinumab in biologic-naïve versus previously biologic-exposed SJIA patients: a 12 week pooled post-hoc analysis

Bibliographic Details
Main Authors: Quartier, P, Grom, A, Ruperto, N, Brunner, HI, Schikler, K, Erguven, M, Goffin, L, Hofer, M, Kallinich, T, Marzan, K, Gaillez, C, Lheritier, K, Abrams, K, Martini, A, Lovell, DJ
Format: Online
Language:English
Published: BioMed Central 2014
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184290/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184290/

Similar Items